| Monthly sulfadoxine–pyrimethamine versus dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled … R Kajubi, T Ochieng, A Kakuru, P Jagannathan, M Nakalembe, T Ruel, ... The Lancet 393 (10179), 1428-1439, 2019 | 100 | 2019 |
| Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting JE Lawn, EO Ohuma, E Bradley, LS Idueta, E Hazel, YB Okwaraji, ... The Lancet 401 (10389), 1707-1719, 2023 | 79 | 2023 |
| Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis ME Roh, FO Ter Kuile, F Rerolle, MM Glymour, S Shiboski, R Gosling, ... The Lancet Global Health 8 (7), e942-e953, 2020 | 49 | 2020 |
| Antiretroviral therapy with efavirenz accentuates pregnancy‐associated reduction of dihydroartemisinin‐piperaquine exposure during malaria chemoprevention R Kajubi, L Huang, P Jagannathan, N Chamankhah, M Were, T Ruel, ... Clinical Pharmacology & Therapeutics 102 (3), 520-528, 2017 | 46 | 2017 |
| Antiretroviral choice for HIV impacts antimalarial exposure and treatment outcomes in Ugandan children S Parikh, R Kajubi, L Huang, J Ssebuliba, S Kiconco, Q Gao, F Li, M Were, ... Reviews of Infectious Diseases 63 (3), 414-422, 2016 | 35 | 2016 |
| Household and maternal risk factors for malaria in pregnancy in a highly endemic area of Uganda: a prospective cohort study J Okiring, P Olwoch, A Kakuru, J Okou, H Ochokoru, TA Ochieng, R Kajubi, ... Malaria journal 18, 1-9, 2019 | 34 | 2019 |
| Artemether-lumefantrine pharmacokinetics and clinical response are minimally altered in pregnant Ugandan women treated for uncomplicated falciparum malaria MM Nyunt, VK Nguyen, R Kajubi, L Huang, J Ssebuliba, S Kiconco, ... Antimicrobial agents and chemotherapy 60 (3), 1274-1282, 2016 | 34 | 2016 |
| Intermittent preventive treatment for malaria in pregnancy: optimization of target concentrations of dihydroartemisinin-piperaquine RM Savic, P Jagannathan, R Kajubi, L Huang, N Zhang, M Were, ... Clinical Infectious Diseases 67 (7), 1079-1088, 2018 | 28 | 2018 |
| Impact of microscopic and submicroscopic parasitemia during pregnancy on placental malaria in a high-transmission setting in Uganda J Briggs, J Ategeka, R Kajubi, T Ochieng, A Kakuru, C Ssemanda, ... The Journal of infectious diseases 220 (3), 457-466, 2019 | 23 | 2019 |
| Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy … A Kakuru, P Jagannathan, R Kajubi, T Ochieng, H Ochokoru, ... BMC medicine 18, 1-11, 2020 | 20 | 2020 |
| Modeling prevention of malaria and selection of drug resistance with different dosing schedules of dihydroartemisinin-piperaquine preventive therapy during pregnancy in Uganda E Wallender, N Zhang, M Conrad, A Kakuru, M Muhindo, P Tumwebaze, ... Antimicrobial agents and chemotherapy 63 (2), 10.1128/aac. 01393-18, 2019 | 16 | 2019 |
| Associations between malaria-preventive regimens and Plasmodium falciparum drug resistance-mediating polymorphisms in Ugandan pregnant women P Nayebare, V Asua, MD Conrad, R Kajubi, A Kakuru, JI Nankabirwa, ... Antimicrobial agents and chemotherapy 64 (12), 10.1128/aac. 01047-20, 2020 | 13 | 2020 |
| Relationships between measures of malaria at delivery and adverse birth outcomes in a high-transmission area of Uganda J Ategeka, A Kakuru, R Kajubi, R Wasswa, H Ochokoru, E Arinaitwe, ... The Journal of infectious diseases 222 (5), 863-870, 2020 | 13 | 2020 |
| Efavirenz-Based Antiretroviral Therapy Reduces Artemether–Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women E Hughes, N Mwebaza, L Huang, R Kajubi, V Nguyen, MM Nyunt, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 83 (2), 140-147, 2020 | 13 | 2020 |
| Piperaquine-induced QTc prolongation decreases with repeated monthly dihydroartemisinin-piperaquine dosing in pregnant Ugandan women E Hughes, E Wallender, R Kajubi, P Jagannathan, T Ochieng, A Kakuru, ... Clinical Infectious Diseases 75 (3), 406-415, 2022 | 10 | 2022 |
| Determination of piperaquine concentration in human plasma and the correlation of capillary versus venous plasma concentrations N Mwebaza, V Cheah, C Forsman, R Kajubi, F Marzan, E Wallender, ... PLoS One 15 (5), e0233893, 2020 | 9 | 2020 |
| Strong correlation of lumefantrine concentrations in capillary and venous plasma from malaria patients L Huang, N Mwebaza, R Kajubi, F Marzan, C Forsman, S Parikh, ... PLoS One 13 (8), e0202082, 2018 | 9 | 2018 |
| Parasite clearance and artemether pharmacokinetics parameters over the course of artemether-lumefantrine treatment for malaria in human immunodeficiency virus (HIV)-infected … R Kajubi, L Huang, M Were, S Kiconco, F Li, F Marzan, D Gingrich, ... Open forum infectious diseases 3 (4), ofw217, 2016 | 9 | 2016 |
| Vulnerable newborn types: analysis of subnational, population‐based birth cohorts for 541 285 live births in 23 countries, 2000–2021 DJ Erchick, EA Hazel, J Katz, ACC Lee, M Diaz, LSF Wu, S Yoshida, ... BJOG: An International Journal of Obstetrics & Gynaecology, 2023 | 8 | 2023 |
| A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda A Nuwa, K Baker, C Bonnington, M Odongo, T Kyagulanyi, JB Bwanika, ... Malaria Journal 22 (1), 63, 2023 | 8 | 2023 |
